Pioglitazone, a Peroxisome Proliferator-Activated Receptor Gamma Activator, Ameliorates Experimental Autoimmune Myocarditis by Modulating Th1/Th2 Balance.

Hiroshi Hasegawa,Hiroyuki Takano,Yunzeng Zou,Yingjie Qin,Kaoru Hizukuri,Kenichi Odaka,Tetsuya Toyozaki,Issei Komuro
DOI: https://doi.org/10.1016/j.yjmcc.2004.11.010
IF: 5.763
2005-01-01
Journal of Molecular and Cellular Cardiology
Abstract:Objectives – The aim of this study is to investigate the effect of Peroxisome proliferator-activated receptor γ (PPARγ) ligand on experimental autoimmune myocarditis (EAM).
What problem does this paper attempt to address?